These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 5443407)

  • 41. Cigarette smoking in relation to the risk of myocardial infarction in young women. Modifying influence of age and predisposing factors.
    Rosenberg L; Shapiro S; Kaufman DW; Slone D; Miettinen OS; Stolley PD
    Int J Epidemiol; 1980 Mar; 9(1):57-63. PubMed ID: 7419331
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Letter: Myocardial infarction and estrogen therapy in premenopausal women.
    Rosenberg L; Armstrong B; Jick H
    N Engl J Med; 1976 Jun; 294(23):1290-1. PubMed ID: 1264157
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Myocardial infarction in young women on oral contraceptives.
    Roth O; Keszler K; Swirsky MH
    Conn Med; 1974 Oct; 38(10):524-7. PubMed ID: 4417836
    [No Abstract]   [Full Text] [Related]  

  • 44. Risk factors for myocardial infarction in young women.
    La Vecchia C; Franceschi S; Decarli A; Pampallona S; Tognoni G
    Am J Epidemiol; 1987 May; 125(5):832-43. PubMed ID: 3565357
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ischaemic heart disease in young women.
    Oliver MF
    Br Med J; 1974 Nov; 4(5939):253-9. PubMed ID: 4425852
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Oral contraceptives and myocardial infarction.
    Bader M
    N Engl J Med; 1977 Aug; 297(8):449. PubMed ID: 882119
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Drospirenone-containing oral contraceptives and risk of adverse outcomes after myocardial infarction.
    Karabay CY; Kocabay G; Oduncu V; Kalayci A; Guler A; Karagöz A; Candan O; Basaran O; Zehir R; Izgi A; Esen AM; Kırma C
    Catheter Cardiovasc Interv; 2013 Sep; 82(3):387-93. PubMed ID: 23361975
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Venous and arterial thrombosis during oral contraceptive use: risks and risk factors.
    Tanis BC; Rosendaal FR
    Semin Vasc Med; 2003 Feb; 3(1):69-84. PubMed ID: 15199494
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study: a case-control study.
    Urbanus RT; Siegerink B; Roest M; Rosendaal FR; de Groot PG; Algra A
    Lancet Neurol; 2009 Nov; 8(11):998-1005. PubMed ID: 19783216
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Acute myocardial infarction and combined oral contraceptives: results of an international multicentre case-control study. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.
    Lancet; 1997 Apr; 349(9060):1202-9. PubMed ID: 9130941
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The prevalence of hyperlipidemia in women and its association with use of oral contraceptives, sex hormone replacement therapy and nonlipid coronary artery disease risk factors. Canadian Heart Health Surveys Research Group.
    Connelly PW; Stachenko S; MacLean DR; Petrasovits A; Little JA
    Can J Cardiol; 1999 Apr; 15(4):419-27. PubMed ID: 10322251
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Myocardial infarction in the young: evolution and clinico-coronarographic correlation (author's transl)].
    Recusani F; De Servi S; Fatica N; Previtali M; Tronconi L; Specchia G
    G Ital Cardiol; 1977; 7(5):441-7. PubMed ID: 873096
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Differences and similarities in ischemic heart disease in men and women].
    Piwowarska W; Zylińska M
    Folia Med Cracov; 1991; 32(1-2):43-56. PubMed ID: 1843699
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Oral contraceptives and nonfatal vascular disease.
    Porter JB; Hunter JR; Jick H; Stergachis A
    Obstet Gynecol; 1985 Jul; 66(1):1-4. PubMed ID: 4011060
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Risk of myocardial infarction in relation to current and discontinued use of oral contraceptives.
    Slone D; Shapiro S; Kaufman DW; Rosenberg L; Miettinen OS; Stolley PD
    N Engl J Med; 1981 Aug; 305(8):420-4. PubMed ID: 7254279
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Coronary disease in women.
    Wenger NK
    Annu Rev Med; 1985; 36():285-94. PubMed ID: 3158267
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Arterial complications of estrogen-progestogen contraception].
    Jaillard J
    Ann Med Interne (Paris); 1983; 134(5):416-20. PubMed ID: 6651062
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Oral contraceptives and cardiovascular disease.
    Dalen JE; Hickler RB
    Am Heart J; 1981 May; 101(5):626-39. PubMed ID: 7223603
    [No Abstract]   [Full Text] [Related]  

  • 59. Smoking, age and the pill.
    McEwan J
    Int J Gynaecol Obstet; 1978-1979; 16(6):529-34. PubMed ID: 39822
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism.
    Godsland IF; Crook D; Simpson R; Proudler T; Felton C; Lees B; Anyaoku V; Devenport M; Wynn V
    N Engl J Med; 1990 Nov; 323(20):1375-81. PubMed ID: 2146499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.